Skip to main content
. 2022 May 24;14(5):e25298. doi: 10.7759/cureus.25298

Table 1. A chronologically-ordered literature review of reported cases of primary vaginal adenocarcinoma of intestinal-type.

CEA: Carcinoembryonic antigen, EMA: Epithelial membrane antigen, CK20: Cytokeratin 20, CK7: Cytokeratin 7, ER: Estrogen receptor, PR: Progesterone receptor, CDX2: Caudal-type homeobox 2, SATB2: Special AT-rich sequence-binding protein 2, TTF-1: Thyroid transcription factor 1, HPV: Human papillomavirus, MMR proteins: Mismatch repair proteins

Authors Patient Age (years) Tumor Size (cm) Tumor Site Immunohistochemical & Other Stains DES exposure
Fukushima et al. [14] (1986) 32 years 3 x 3 x 2 cm Distal third of the vaginal wall Neuroendocrine markers were expressed due to mixed components Unknown
Fox et al. [6] (1988) 35 years 5 x 2 cm Left lateral and anterior vaginal wall Unknown Unknown
Yaghsezian et al. [15] (1992) 52 years 1 cm Posterior distal vaginal wall Unknown Not present
Nagar et al. [16] (1999) 36 years Depth only: 0.1 cm Upper anterior vaginal wall Not reported Not present
Heller et al. case 1 [17] (2000) 55 years 7 x 4 cm Anterior lower vaginal wall CEA+, EMA+ Not present
Heller et al. case 2 [17] (2000) 52 years 2.5 cm Anterior lower vaginal wall CEA+, EMA+ Not present
Mudhar et al. [18] (2001) 56 years 1 cm Distal posterior vaginal wall CEA+, CK20+, CK7- Not present
Tjalma and Colpaert et al. [19] (2006) 55 years 4.5 x 4 x 2.7 cm Anterior lower and posterior vaginal walls CEA+, CK20+, CK7+, ER-, PR- Unknown
Ditto et al. [1] (2007) 53 years 1 x 2 cm Distal posterior vaginal wall CK20+, CDX2+, CK7- Not present
Driss et al. [20] (2007) 70 years 4 cm Anterior lower and middle vaginal walls CEA+, CK20+, EMA+, CK7- Not present
van Wessel et al. [21] (2013) 68 years 1 x 1.3 cm Posterior wall of vaginal introitus CEA+, CK20+, CK7+ Not present
Staats et al. [22] 10 cases (2014) Range: 36 to 86 years Range: 0.8 to 1.5 cm Variable CEA+, CK20+, CDX2+, CK (+/-), ER-, PR- Not present in most cases, few could not be excluded
Tatsumi et al. [3] (2015) 64 years 2 cm Posterior vaginal wall CK20+, CDX2+, CK7+ (focal), ER- Present
Broggi et al. [23] (2018) 51 years 2 cm Posterior wall of vaginal introitus CEA+, CK20+, CDX2+, CK7+ (focal), ER-, PR- Not reported
Ugwu et al. [9] (2019) 40 years 6 x 3 cm Posterior wall of the lower-third of the vagina with extension to the introitus Not reported Not reported
Current case (2022) 62 years Bilobed components: 1.8 cm, and 2.3 cm Bilobed components: Middle one-third of the vagina, and lower one-third of the vagina (respective to size) CEA+, CK20+, CDX2+, EMA+ (focal), SATB2+, TTF-1+ (patchy) CK7-, ER-, PR-, p16-, GATA3- In-situ hybridization for high-risk HPV – MMR proteins - Not present